Doxazosin Mesylate Market

Doxazosin mesylate, a quinazoline compound, is an ?1-selective alpha blocker used to treat high blood pressure and urinary retention associated with benign prostatic hyperplasia (BPH).It relaxes your veins and arteries so that blood can more easily pass through them. It also relaxes the muscles in the prostate and bladder neck, making it easier to urinate.

Doxazosin Mesylate Market contains market size and forecasts of Doxazosin Mesylate in global, including the following market information:

• Global Doxazosin Mesylate Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Doxazosin Mesylate Market Sales, 2017-2022, 2023-2028, (M Pcs)
• Global top five Doxazosin Mesylate companies in 2021 (%)

The global Doxazosin Mesylate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Immediate-release Tablet (1 mg, 2 mg, 4 mg, and 8 mg) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Doxazosin Mesylate include Pfizer, Upsher-Smith Laboratories, Zydus Pharmaceuticals, Heritage Pharmaceuticals, Accord Healthcare, Par Pharmaceuticals, APOTEX, Hefei Lifeon Pharmaceutical and Shandong ShanChuan Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Doxazosin Mesylate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Doxazosin Mesylate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)

Global Doxazosin Mesylate Market Segment Percentages, by Type, 2021 (%)

• Oral Immediate-release Tablet (1 mg, 2 mg, 4 mg, and 8 mg)
• Oral Extended-release Tablet (4 mg and 8 mg)

Global Doxazosin Mesylate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)

Global Doxazosin Mesylate Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Retail Pharmacy
• Others

Global Doxazosin Mesylate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)

Global Doxazosin Mesylate Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Doxazosin Mesylate revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Doxazosin Mesylate revenues share in global market, 2021 (%)
• Key companies Doxazosin Mesylate sales in global market, 2017-2022 (Estimated), (M Pcs)
• Key companies Doxazosin Mesylate sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Upsher-Smith Laboratories
• Zydus Pharmaceuticals
• Heritage Pharmaceuticals
• Accord Healthcare
• Par Pharmaceuticals
• APOTEX
• Hefei Lifeon Pharmaceutical
• Shandong ShanChuan Pharmaceutical
• Kangmei Pharmaceutical
• Zhejiang CONBA Pharmaceutical